MedTrace Logo

A Registered Cohort Study on Amyotrophic Lateral Sclerosis

NCT04008329 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2021-03-22

No results posted yet for this study

Summary

Amyotrophic lateral sclerosis (ALS) is a kind of motor neuron degeneration disorder without effective therapy. This registered cohort study will provide further insights into the clinical course of ALS, and investigate disease-relative risk factors and the genetic background of Chinese ALS patients.

Conditions

Sponsors & Collaborators

  • First Affiliated Hospital of Fujian Medical University

    lead OTHER

Principal Investigators

  • Ning Wang, MD,PhD · First Affiliated Hospital of Fujian Medical University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-05
Primary Completion
2029-07-31
Completion
2059-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04008329 on ClinicalTrials.gov